SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will attend or present at three events in October. The company’s agenda includes a number of high-profile scientific and investment conferences, following a recent presentation of data at the ESMO 2014 Congress.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
